Multicomponent adsorber for medical use
Reference number | |
Coordinator | Alteco Medical AB |
Funding from Vinnova | SEK 1 548 734 |
Project duration | March 2021 - December 2023 |
Status | Completed |
Venture | Innovation projects in enterprises |
Call | Innovation projects in SMEs 2020 |
Important results from the project
** Denna text är maskinöversatt ** The aim of this project is to develop and launch a new product based on the innovative multi-component adsorber which is now patented. The goal is to offer the market a product that can effectively stabilize seriously ill patients, where the risk of kidney failure, organ failure and death is palpable. Through this innovation, we aim to significantly improve treatment options and quality of life for these patients.
Expected long term effects
** Denna text är maskinöversatt ** The results show a significant improvement in the adsorption of endotoxins and cytokines. The project´s extended timeline is due to challenges such as difficulty accessing expertise due to pandemic effects, increased material costs, and significant reduced funding due to international concerns related to the war situation in the immediate area. Despite these obstacles, we continue to drive the project with a focus on delivering a breakthrough product to improve the treatment of seriously ill patients.
Approach and implementation
** Denna text är maskinöversatt ** The company´s original ambition has been to follow the plan established at the start of the project. Despite the challenges mentioned earlier, it has been difficult to maintain the original time frame. Important to emphasize, however, is the company´s continued endeavor to quickly complete the project. To increase the speed of development, we are looking for external capital. The interest from potential industrial partners strengthens our belief that the product has significant potential in the market.